Castle Biosciences Inc (CSTL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 85,556 | 82,233 | 89,689 | 119,709 | 94,959 |
| Marketable Securities | 201,986 | 193,697 | 185,462 | 173,421 | 184,826 |
| Receivables | 49,482 | 52,311 | 56,353 | 51,218 | 50,261 |
| Inventories | 8,650 | 8,366 | 6,849 | 8,135 | 6,572 |
| TOTAL | $357,569 | $348,668 | $349,388 | $360,154 | $344,772 |
| Non-Current Assets | |||||
| PPE Net | 84,885 | 74,060 | 55,423 | 51,122 | 44,383 |
| Investments And Advances | 0 | 0 | 5,570 | 0 | 0 |
| Other Non-Current Assets | 120,332 | 122,001 | 91,334 | 119,959 | 125,410 |
| TOTAL | $205,217 | $196,061 | $152,327 | $171,081 | $169,793 |
| Total Assets | $562,786 | $544,729 | $501,715 | $531,235 | $514,565 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 0 | 1,944 | 1,111 | 278 | N/A |
| Accounts payable and accrued liabilities | 12,211 | 13,181 | 8,502 | 6,901 | 6,810 |
| Accrued Expenses | 31,763 | 24,973 | 17,857 | 32,555 | 27,672 |
| Other current liabilities | 1,000 | 1,000 | N/A | N/A | N/A |
| TOTAL | $55,308 | $50,890 | $37,274 | $49,392 | $44,295 |
| Non-Current Liabilities | |||||
| Long Term Debt | 10,049 | 8,096 | 8,921 | 9,745 | 10,015 |
| Other Non-Current Liabilities | 26,802 | 26,877 | 14,049 | 14,345 | 14,691 |
| TOTAL | $40,432 | $38,463 | $24,135 | $26,008 | $29,215 |
| Total Liabilities | $95,740 | $89,353 | $61,409 | $75,400 | $73,510 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 29,189 | 29,008 | 28,872 | 28,514 | 28,007 |
| Common Shares | 29 | 29 | 29 | 28 | 28 |
| Retained earnings | -221,952 | -221,451 | -225,974 | -200,126 | -209,716 |
| Other shareholders' equity | 240 | 39 | 131 | 230 | 473 |
| TOTAL | $467,046 | $455,376 | $440,306 | $455,835 | $441,055 |
| Total Liabilities And Equity | $562,786 | $544,729 | $501,715 | $531,235 | $514,565 |